Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q4 2022 Earnings Call Transcript
Operator: Good day, and welcome to the Tandem Diabetes Care Fourth Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Tandem Diabetes Care Inc (TNDM)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Eminence Capital Ricky Sandler | 2,783,473 | $125,117,111 | +75% | 2.32% |
| 2. | Two Sigma Advisors John Overdeck And David Siegel | 961,083 | $43,200,681 | +38% | 0.12% |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 881,307 | $39,614,750 | 0.08% | |
| 4. | Balyasny Asset Management Dmitry Balyasny | 580,895 | $26,111,231 | +98% | 0.07% |
| 5. | Octagon Capital Advisors Ting Jia | 474,929 | $21,348,059 | 3.32% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $70.00 | 500 | Officer | 9,118 | 2022-05-09 | Filing | |
| $74.90 | 1,000 | Officer | 8,618 | 2022-05-06 | Filing | |
| $76.63 | 1,000 | Officer | 7,618 | 2022-05-06 | Filing | |
| $69.90 | 2,500 | Officer, Director | 10,058 | 2022-05-09 | Filing | |
| $74.58 | 483 | Director | 2,948 | 2022-05-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $41.19 | 10,000 | Officer | 3,365 | 2023-03-03 | Filing | |
| $40.25 | 10,000 | Officer | 3,029 | 2022-12-16 | Filing | |
| $40.32 | 15,000 | Officer | 3,029 | 2022-12-15 | Filing | |
| $65.00 | 3,097 | Officer | 2,457 | 2022-06-08 | Filing | |
| $65.03 | 7,000 | Officer | 5,554 | 2022-06-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 9,642,007 | $433,408,202 | 0.04% | |
| 2. | 6,346,440 | $285,272,478 | 0% | |
| 3. | 6,127,229 | $275,418,944 | 0% | |
| 4. | 4,850,184 | $218,015,771 | 0.04% | |
| 5. | 3,068,863 | $137,945,392 | 0.88% |
News See All
12 Most Promising Medical Stocks According to Analysts
Regardless of the short-term market situation, the healthcare industry has a huge growth potential.
Tandem Diabetes Care (TNDM) Stock Declined in Q3 Due to Competition
Chartwell Investment Partners, an affiliate of Carillon Tower Advisers, an investment management company, released its “Carillon Chartwell Small Cap Growth Fund” third quarter 2022 investor letter...
11 Best Diabetes Stocks To Buy Now
The global diabetes market is segmented based on the type, drug class, and devices used to treat the condition.
10 Best Diabetes Stocks To Buy Now
The diabetes market has grown in the past few years as organizations and individuals in the private and public domains make significant investments in the sector to generate awareness about early and ...
3 Medical Stocks to Buy According to Mitchell Blutt's Consonance Capital
In this article, we will be looking at the 3 medical stocks to buy according to Mitchell Blutt's Consonance Capital.
Were Expert Investors Right About Tandem Diabetes Care Inc (TNDM)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
10 Biotech Stocks in Billionaire Ray Dalio's Portfolio
In this piece, we will take a look at the 10 biotech stocks in billionaire Ray Dalio's portfolio. If you want to jump ahead to the top five stocks in the list and skip the details about Mr.
Is Tandem Diabetes Care Inc (TNDM) A Good Stock To Buy?
We at Insider Monkey have gone over 867 13F filings that hedge funds and prominent investors are required to file by the SEC.
Jim Cramer Stock Portfolio: 10 Recent Additions
In this article, we discuss the 10 recent additions to the stock portfolio of Jim Cramer.
Billionaire Hedge Funds
